- Home
- PATK vs MRUS Comparison
PATK vs MRUS Comparison
Compare PATK & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PATK
- MRUS
- Stock Information
- Founded
- PATK 1959
- MRUS 2003
- Country
- PATK United States
- MRUS Netherlands
- Employees
- PATK N/A
- MRUS N/A
- Industry
- PATK Auto Parts:O.E.M.
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- PATK Consumer Discretionary
- MRUS Health Care
- Exchange
- PATK Nasdaq
- MRUS Nasdaq
- Market Cap
- PATK 2.7B
- MRUS 2.7B
- IPO Year
- PATK N/A
- MRUS 2016
- Fundamental
- Price
- PATK $82.88
- MRUS $42.03
- Analyst Decision
- PATK Buy
- MRUS Strong Buy
- Analyst Count
- PATK 10
- MRUS 14
- Target Price
- PATK $101.53
- MRUS $87.00
- AVG Volume (30 Days)
- PATK 459.9K
- MRUS 786.0K
- Earning Date
- PATK 05-01-2025
- MRUS 05-07-2025
- Dividend Yield
- PATK 2.31%
- MRUS N/A
- EPS Growth
- PATK N/A
- MRUS N/A
- EPS
- PATK 4.16
- MRUS N/A
- Revenue
- PATK $3,785,611,000.00
- MRUS $54,732,000.00
- Revenue This Year
- PATK $8.30
- MRUS $26.81
- Revenue Next Year
- PATK $6.51
- MRUS $23.85
- P/E Ratio
- PATK $19.97
- MRUS N/A
- Revenue Growth
- PATK 8.12
- MRUS N/A
- 52 Week Low
- PATK $67.72
- MRUS $33.19
- 52 Week High
- PATK $98.90
- MRUS $61.61
- Technical
- Relative Strength Index (RSI)
- PATK 55.35
- MRUS 50.29
- Support Level
- PATK $80.35
- MRUS $37.92
- Resistance Level
- PATK $84.20
- MRUS $46.36
- Average True Range (ATR)
- PATK 3.21
- MRUS 2.44
- MACD
- PATK 0.73
- MRUS -0.13
- Stochastic Oscillator
- PATK 92.45
- MRUS 60.55
About PATK Patrick Industries Inc.
Patrick Industries Inc makes and sells building products and materials for recreational vehicles and manufactured housing. The company is organized into two segments based on product type: manufacturing and distribution. The manufacturing segment, which generates the majority of revenue, sells laminated and vinyl products that include furniture, shelving, cabinets, bath fixtures, and countertops. The distribution segment sells prefinished wall and ceiling panels, as well as electrical and plumbing products for the RV and manufactured housing industries. One of the firm's RV customers makes up a portion of revenue.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.